Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
1 other identifier
interventional
54
0 countries
N/A
Brief Summary
subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 11, 2021
CompletedFirst Posted
Study publicly available on registry
August 13, 2021
CompletedAugust 13, 2021
August 1, 2021
1.4 years
August 11, 2021
August 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Vestibular time constant
Vestibular time constant was measured using repeated rotatory chair stimulation in step protocol.
Until one month following the intervention
Seasickness severity
Seasickness severity as determined by Wiker questionnaire at set time frames following the intervention
Until one month following the intervention
scopolamine drug prescription
scopolamine drug prescriptions were calculated for each participant and compared between the two groups
Until three months following the intervention
Anti-motion sickness clinic visits
Anti-motion sickness clinic visits were calculated for each participant and compared between the two groups
Until three months following the intervention
Study Arms (2)
sham procedure
SHAM COMPARATORParticipants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.
GVS stimulation coupled with inverse phase rotatory chair stimulation
EXPERIMENTALParticipants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. The rotatory chair was activated in sinusoidal harmonic acceleration protocol in inverse phase to galvanic vestibular stimulation.
Interventions
GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol
Participants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.
Eligibility Criteria
You may qualify if:
- maximum score of 7 on the Wiker seasickness questionnaire in moderate sea conditions, with wave height of 0 - 1.5 m
- All had been sailing regularly for at least six months before enrolling in the study
You may not qualify if:
- history of hearing loss
- otoscopic findings of ear pathology
- an implanted electrode
- a finding of vestibulopathy on otoneurologic examination
- withdrawal by any subject of his informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Gutkovich YE, Lagami D, Jamison A, Fonar Y, Tal D. Galvanic vestibular stimulation as a novel treatment for seasickness. Exp Brain Res. 2022 Feb;240(2):429-437. doi: 10.1007/s00221-021-06263-w. Epub 2021 Nov 15.
PMID: 34782915DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dror Tal, PhD
The Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2021
First Posted
August 13, 2021
Study Start
August 1, 2016
Primary Completion
January 1, 2018
Study Completion
July 1, 2019
Last Updated
August 13, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share